Announced Thu, 6 Aug · 19:10 IST
Board meeting on 13 Aug to approve Q1 FY27 results
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹60.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.1-1.7+3.3+8.4+4.0-1.0+14.5+12.4——
Up moveDown movePending
AI summary
Brooks Laboratories has informed exchanges that its Board will meet on 13 August 2026 to consider and approve unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended 30 June 2026), along with the limited review report of statutory auditors. The trading window for directors, designated persons and their immediate relatives has been closed since 1 July 2026 and will reopen 48 hours after the results are declared.
Likely market impact
Routine advance intimation. Investors should watch for Q1 FY27 results announcement on or after 13 August 2026.